New scan could spot cancers without a needle

NCT ID NCT07510321

Recruiting now Diagnosis Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Apr 10, 2026 · Last updated May 16, 2026 · Updated 3 times

Summary

This early study is testing a new imaging agent called FL-261 to see if it can safely and accurately detect and stage several types of cancer, including lung, colorectal, and head & neck cancers. The agent targets a protein (c-MET) found on many cancer cells but not on most healthy cells. About 12 adults with advanced solid tumors will receive a radioactive form of FL-261 and then have a PET or SPECT scan. The goal is to see if this scan can find tumors and their spread as well as or better than current methods, potentially reducing the need for invasive biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Wuhan Union Hospital
RECRUITING

Wuhan, Hubei, 430022, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS ADVANCED SOLID TUMORS COLORECTAL CANCER HEAD & NECK CANCER HEAD & NECK CANCER NON-SMALL CELL LUNG CANCER